SCHEMBL157377

SCHEMBL157377

COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(C(=O)NCC(C)CC(F)(F)F)cc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30494611 1.00
SCHEMBL30494589 1.00
SCHEMBL157376 1.00
SCHEMBL8427210 0.90
SCHEMBL9472459 0.86
SCHEMBL9472457 0.86
SCHEMBL8532662 0.86
SCHEMBL9293941 0.86
SCHEMBL8533700 0.86
SCHEMBL8532769 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0489547-B1 A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof ZENECA LTD (GB) 1998-07-29 EP claimed
EP-0432984-B1 Carbamoyl derivatives ZENECA LTD (GB) 1998-03-04 EP claimed
US-5466826-A Crystallization of indole derivative from solvents as antiasthmatics IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) 1995-11-14 US claimed
US-5352694-A 3-methoxy-4(1-methyl-5(2-methyl-4,4,4-trifluorobutylcarbamoyl) indole-3-ylmethyl)-N-(2-methylphenylsulphonyl) benzamide; leukotriene antagonist used for asthma treatment IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-10-04 US claimed
US-5286740-A Leukotrine antagonists; antiinflammatory agnets, antiallergens, treating asthma IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-02-15 US claimed
US-5274118-A Process for preparing (2R)-methyl-4,4,4-trifluorobutylamine IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-12-28 US claimed
EP-0489547-A1 A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof ZENECA LIMITED (GB) 1992-06-10 EP claimed
EP-0432984-A2 Carbamoyl derivatives ZENECA LIMITED (GB) 1991-06-19 EP claimed
JP-7070061-A None JP disclosed
JP-5194385-A None JP disclosed
US-20250092042-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 2025-03-20 US disclosed
US-20220008400-A1 METHODS OF TREATING AUTOIMMUNE, RESPIRATORY AND INFLAMMATORY DISORDERS BY INHALATION OF ROFLUMILAST N-OXIDE INCOZEN THERAPEUTICS PVT LTD (IN) 2022-01-13 US disclosed
EP-3763366-A1 ROFLUMILAST N-OXIDE FOR USE IN TREATING AUTOIMMUNE, RESPIRATORY AND INFLAMMATORY DISORDERS BY INHALATION Incozen Therapeutics Pvt. Ltd. (IN) 2021-01-13 EP disclosed
EP-2948148-B1 METHODS OF TREATING AUTOIMMUNE, RESPIRATORY AND INFLAMMATORY DISORDERS BY INHALATION OF ROFLUMILAST N-OXIDE INCOZEN THERAPEUTICS PVT LTD (IN) 2020-07-29 EP disclosed
US-5274118-A Process for preparing (2R)-methyl-4,4,4-trifluorobutylamine IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-12-28 US disclosed
US-5274118-A Process for preparing (2R)-methyl-4,4,4-trifluorobutylamine IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-12-28 US disclosed
JP-H05194385-A PHARMACEUTICAL AGENT IMPERIAL CHEM IND PLC <ICI> 1993-08-03 JP disclosed
EP-0489548-A1 A process for the preparation of 2(R)-methyl-4,4,4-trifluorobutylamine, intermediates, and a process for the preparation of a derivative thereof ZENECA LIMITED (GB) 1992-06-10 EP disclosed
EP-0489547-A1 A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof ZENECA LIMITED (GB) 1992-06-10 EP disclosed
EP-0432984-A2 Carbamoyl derivatives ZENECA LIMITED (GB) 1991-06-19 EP disclosed